Thromboprophylaxis in Critically Ill Coronavirus Disease 2019 Patients

It is now reported that coronavirus disease 2019 ICU patients are at increased risk of thrombosis. Expert opinion and scientific societies recommend a higher dose of low-molecular-weight heparin, but definitive data is lacking. We report our adapted thromboprophylaxis practice of low-molecular-weigh...

Descripción completa

Detalles Bibliográficos
Autores principales: Piagnerelli, Michaël, Cauchie, Philippe, Vancutsem, Maxime, Thooft, Aurélie, Zouaoui Boudjeltia, Karim, Biston, Patrick, Wautrecht, Jean-Claude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392617/
https://www.ncbi.nlm.nih.gov/pubmed/32766568
http://dx.doi.org/10.1097/CCE.0000000000000177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392617/
https://www.ncbi.nlm.nih.gov/pubmed/32766568
http://dx.doi.org/10.1097/CCE.0000000000000177

Ejemplares similares